Thomas Seng
Impact in
- Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity
-
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- Mitochondrial Function and Pathology 2
- Signaling Pathways in Disease 1
- Metabolism, Diabetes, and Cancer 1
-
- Apelin-related biomedical research 1
- Co-authors
- Robert E. Handschumacher (1 shared paper)David G. Osterman (1 shared paper)Richard M. Bayney (1 shared paper)Michael A. Statnick (1 shared paper)D. Brooke Johnson (1 shared paper)Todd M. Suter (1 shared paper)F. José (1 shared paper)Helena Corominola (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Medicinal Chemistry (1 paper)Virology (1 paper)Journal of Biological Chemistry (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United States
In The Last Decade
Thomas Seng
8 papers receiving 429 citations
Peers
Comparison fields: 5 of 67
- Endocrine and Autonomic Systems 81
- Epidemiology 173
- Physiology 127
- Immunology 69
- Cardiology and Cardiovascular Medicine 74
Countries citing papers authored by Thomas Seng
This map shows the geographic impact of Thomas Seng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Seng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Seng more than expected).
Fields of papers citing papers by Thomas Seng
This network shows the impact of papers produced by Thomas Seng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Seng. The network helps show where Thomas Seng may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Seng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 178 | |
| 2 | 1993 | 114 | |
| 3 | 1992 | 61 | |
| 4 | 2004 | 31 | |
| 5 | 2016 | 25 | |
| 6 | 2016 | 20 | |
| 7 | 2003 | 12 | |
| 8 | 1997 | 1 |
About Thomas Seng
Thomas Seng is a scholar working on Molecular Biology, Pharmacology, Clinical Biochemistry, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 8 papers that have together received 442 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (3 papers), Metabolism and Genetic Disorders (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Mitochondrial Function and Pathology (2 papers), Signaling Pathways in Disease (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Apelin-related biomedical research (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Endocrine and Autonomic Systems (81 citations), Epidemiology (173 citations), Physiology (127 citations), Immunology (69 citations) and Cardiology and Cardiovascular Medicine (74 citations). Thomas Seng has collaborated with scholars based in United States. Frequent co-authors include Robert E. Handschumacher, David G. Osterman, Richard M. Bayney, Michael A. Statnick, D. Brooke Johnson, Todd M. Suter, F. José, Helena Corominola, Lisa S. Beavers and Éric Ravussin. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry, Virology, Journal of Biological Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.